Masayuki Sho Selected Research

Masayuki Sho Research Topics

Disease

64	Neoplasms (Cancer) 12/2023 - 04/2003
46	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 04/2003
31	Neoplasm Metastasis (Metastasis) 09/2023 - 11/2009
26	Adenocarcinoma 12/2023 - 11/2014
12	Stomach Neoplasms (Stomach Cancer) 02/2024 - 07/2010
10	Pancreatic Fistula (Pancreatic Fistulas) 01/2022 - 02/2013
9	Lymphatic Metastasis 01/2022 - 06/2015
8	Esophageal Neoplasms (Esophageal Cancer) 04/2024 - 04/2005
7	Inflammation (Inflammations) 10/2022 - 08/2003
6	Hemorrhage 10/2023 - 12/2017
6	Reperfusion Injury 11/2019 - 05/2005
5	Adenoma (Adenomas) 01/2022 - 03/2015
5	Disease Progression 01/2022 - 04/2010
5	Colonic Neoplasms (Colon Cancer) 01/2022 - 11/2010
4	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 01/2015
3	Rectal Neoplasms (Rectal Cancer) 11/2023 - 01/2018
3	Surgical Wound Infection 01/2023 - 04/2016
3	Polyps 10/2022 - 03/2015
3	Esophageal Squamous Cell Carcinoma 05/2022 - 03/2014
3	Non-alcoholic Fatty Liver Disease 04/2022 - 03/2014
3	Pneumonia (Pneumonitis) 01/2022 - 12/2005
3	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 06/2024 - 04/2021
2	Hypoxia (Hypoxemia) 02/2024 - 04/2023
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2023 - 01/2023
2	Sarcopenia 11/2023 - 12/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2023 - 01/2011
2	Neoplasms, Cystic, Mucinous, and Serous 01/2023 - 07/2019
2	Renal Insufficiency (Renal Failure) 01/2021 - 11/2015
2	Body Weight (Weight, Body) 01/2021 - 11/2018
2	Carcinoma (Carcinomatosis) 10/2020 - 09/2015
2	Residual Neoplasm 02/2019 - 11/2010
2	Fatigue 01/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

18	Gemcitabine FDA Link 12/2023 - 04/2007
10	Biomarkers (Surrogate Marker)IBA 03/2023 - 06/2016
9	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 01/2013
7	AntigensIBA 12/2023 - 04/2010
7	Fluorouracil (Carac)FDA LinkGeneric 09/2020 - 11/2009
6	CarbohydratesIBA 12/2023 - 02/2019
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 08/2003
6	Proteins (Proteins, Gene)FDA Link 05/2020 - 04/2003
5	Tumor Biomarkers (Tumor Markers)IBA 09/2023 - 01/2017
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 01/2013
5	Irinotecan (Camptosar)FDA LinkGeneric 10/2020 - 01/2016
5	Small Interfering RNA (siRNA)IBA 09/2020 - 04/2010
4	Member 14 Tumor Necrosis Factor ReceptorsIBA 11/2019 - 03/2014
3	EnzymesIBA 04/2022 - 03/2014
3	CytokinesIBA 01/2020 - 08/2003
3	degradable starch microspheresIBA 03/2017 - 01/2013
3	PowdersIBA 03/2017 - 01/2013
3	LigandsIBA 02/2009 - 04/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 04/2023
2	Therapeutic UsesIBA 10/2023 - 01/2011
2	C-Reactive ProteinIBA 01/2023 - 11/2018
2	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2020
2	InterferonsIBA 10/2022 - 05/2013
2	Hemoglobins (Hemoglobin)IBA 09/2022 - 08/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2022 - 01/2013
2	Alanine Transaminase (SGPT)IBA 04/2022 - 01/2013
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 04/2003
2	Carcinoembryonic AntigenIBA 09/2021 - 11/2018
2	Serum AlbuminIBA 01/2021 - 11/2018
2	Leucovorin (Folinic Acid)FDA Link 10/2020 - 01/2013
2	tegafur-gimeracil-oteracilIBA 10/2020 - 12/2017
2	Docetaxel (Taxotere)FDA Link 09/2020 - 10/2017
2	Claudin-4IBA 11/2019 - 03/2019
2	von Willebrand FactorIBA 11/2019 - 01/2018
2	folfirinoxIBA 11/2019 - 01/2019
2	N-acetyltalosaminuronic acid (NAT)IBA 06/2019 - 07/2015
2	Fibrinogen (Factor I)FDA Link 04/2019 - 01/2017
2	Pancrelipase (Creon)FDA Link 03/2016 - 03/2014
2	Monoclonal AntibodiesIBA 01/2011 - 04/2007

Therapy/Procedure

34	Drug Therapy (Chemotherapy) 06/2024 - 04/2009
25	Neoadjuvant Therapy 01/2024 - 11/2011
21	Pancreaticoduodenectomy 08/2023 - 11/2009
20	Therapeutics 10/2023 - 12/2005
16	Pancreatectomy 12/2023 - 04/2012
10	Adjuvant Chemotherapy 06/2024 - 11/2009
7	Operative Surgical Procedures 06/2024 - 03/2014
6	Length of Stay 06/2024 - 02/2013
6	Esophagectomy 04/2024 - 11/2018
6	Hepatectomy 12/2023 - 11/2019
6	Gastrectomy 09/2022 - 07/2010
4	Splenectomy 02/2023 - 03/2013
4	Combination Drug Therapy (Combination Chemotherapy) 09/2020 - 11/2009
3	Stents 01/2023 - 02/2019
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2023 - 06/2018
3	Blood Transfusion (Blood Transfusions) 01/2021 - 01/2016
3	Chemoradiotherapy 01/2021 - 11/2011
3	Pancreaticojejunostomy 07/2020 - 01/2016
3	Radiotherapy 06/2019 - 11/2010
3	Ligation 02/2019 - 08/2003
3	Operative Time 01/2018 - 01/2017
3	Combined Modality Therapy 11/2016 - 11/2010
2	Immunotherapy 05/2022 - 04/2005
2	Sutures (Suture) 05/2022 - 04/2021
2	Colectomy 01/2022 - 11/2010
2	Microspheres (Microsphere) 08/2019 - 03/2017
2	Catheters 06/2016 - 11/2011
2	Vascular Access Devices (Arterial Line) 06/2016 - 06/2012